Association between Active Mobility Index and sarcopenia among Japanese community-dwelling older adults.
Life space
Musculoskeletal disease
Physical activity
Social activity
Journal
Journal of cachexia, sarcopenia and muscle
ISSN: 2190-6009
Titre abrégé: J Cachexia Sarcopenia Muscle
Pays: Germany
ID NLM: 101552883
Informations de publication
Date de publication:
06 2022
06 2022
Historique:
revised:
14
02
2022
received:
03
01
2022
accepted:
10
03
2022
pubmed:
20
4
2022
medline:
11
6
2022
entrez:
19
4
2022
Statut:
ppublish
Résumé
A physically active lifestyle, including physical and social activities, is needed to maintain muscle mass, strength, and physical performance. A large life space characterizes an active lifestyle, but the association between life space with physical and social activities and sarcopenia is unclear. This study aimed to examine the association between life space with physical and social activities, assessed using the Active Mobility Index (AMI), and sarcopenia in community-dwelling Japanese older adults. This study used a large, cross-sectional cohort dataset from the National Center for Geriatrics and Gerontology-Study of Geriatric Syndromes (NCGG-SGS). Between 2013 and 2018, community-dwelling Japanese adults aged ≥60 years participated in the NCGG-SGS. Sarcopenia was identified by measuring muscle mass and strength based on the clinical definition. The secondary outcomes were sarcopenia indices, including lower muscle mass, lower muscle strength, and lower gait speed. AMI assessed life space with physical and social activities in each life space (distance from the respondent's home: <1, 1-10, or >10 km) during the past month by noting the frequency, primary purpose, type of transportation, interaction with others, and physical activity. The associations between quartile groups of AMI total, physical, and social scores and sarcopenia were examined using a logistic regression model. From all participants, 21 644 participants (age 73.5 ± 5.8 years, 54.7% female) were included in the analysis. The prevalence of sarcopenia was 4.1% (n = 894). For the AMI total score, referred to Q1 group, Q3 and Q4 groups were significantly associated with a reduced odds ratio (OR) of sarcopenia after adjusting for all covariates [adjusted OR (aOR) (95% confidence interval), Q3: 0.71 (0.57-0.89), Q4: 0.69 (0.55-0.87)]. Q3 and Q4 of the AMI physical score groups were also significantly associated with reduced OR of sarcopenia [Q3: 0.71 (0.57-0.89), Q4: 0.67 (0.54-0.84)]. For the AMI social score, only the Q4 group showed reduced OR for sarcopenia [0.79 (0.62-1.01)]. Q3 and Q4 of the AMI total score and physical score were associated with reduced OR of all sarcopenia indices (aOR 0.55-0.82, all P < 0.05), whereas Q4 of AMI social score was associated with all indices (aOR 0.85-0.81, all P < 0.05). The extent of life space with physical activity was associated with sarcopenia in community-dwelling older adults. A longitudinal study is needed to examine whether life space with physical and social activities affect the development of sarcopenia.
Sections du résumé
BACKGROUND
A physically active lifestyle, including physical and social activities, is needed to maintain muscle mass, strength, and physical performance. A large life space characterizes an active lifestyle, but the association between life space with physical and social activities and sarcopenia is unclear. This study aimed to examine the association between life space with physical and social activities, assessed using the Active Mobility Index (AMI), and sarcopenia in community-dwelling Japanese older adults.
METHODS
This study used a large, cross-sectional cohort dataset from the National Center for Geriatrics and Gerontology-Study of Geriatric Syndromes (NCGG-SGS). Between 2013 and 2018, community-dwelling Japanese adults aged ≥60 years participated in the NCGG-SGS. Sarcopenia was identified by measuring muscle mass and strength based on the clinical definition. The secondary outcomes were sarcopenia indices, including lower muscle mass, lower muscle strength, and lower gait speed. AMI assessed life space with physical and social activities in each life space (distance from the respondent's home: <1, 1-10, or >10 km) during the past month by noting the frequency, primary purpose, type of transportation, interaction with others, and physical activity. The associations between quartile groups of AMI total, physical, and social scores and sarcopenia were examined using a logistic regression model.
RESULTS
From all participants, 21 644 participants (age 73.5 ± 5.8 years, 54.7% female) were included in the analysis. The prevalence of sarcopenia was 4.1% (n = 894). For the AMI total score, referred to Q1 group, Q3 and Q4 groups were significantly associated with a reduced odds ratio (OR) of sarcopenia after adjusting for all covariates [adjusted OR (aOR) (95% confidence interval), Q3: 0.71 (0.57-0.89), Q4: 0.69 (0.55-0.87)]. Q3 and Q4 of the AMI physical score groups were also significantly associated with reduced OR of sarcopenia [Q3: 0.71 (0.57-0.89), Q4: 0.67 (0.54-0.84)]. For the AMI social score, only the Q4 group showed reduced OR for sarcopenia [0.79 (0.62-1.01)]. Q3 and Q4 of the AMI total score and physical score were associated with reduced OR of all sarcopenia indices (aOR 0.55-0.82, all P < 0.05), whereas Q4 of AMI social score was associated with all indices (aOR 0.85-0.81, all P < 0.05).
CONCLUSIONS
The extent of life space with physical activity was associated with sarcopenia in community-dwelling older adults. A longitudinal study is needed to examine whether life space with physical and social activities affect the development of sarcopenia.
Identifiants
pubmed: 35437935
doi: 10.1002/jcsm.12994
pmc: PMC9178158
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1919-1926Subventions
Organisme : Japan Society for the Promotion of Science (JSPS) KAKENHI
ID : JP20K19665
Organisme : Funds of Obu City Local Government
Organisme : Research Project on Health and Welfare Promotion for the Elderly
Organisme : Grant-in-Aid for Young Scientists (A)
ID : 26702033
Organisme : Grant-in-Aid for Scientific Research (B)
ID : 18H03185
Organisme : Japanese Ministry of Health, Labour and Welfare
ID : H29-ninchisho-ippan-002
Organisme : Japanese Ministry of Health, Labour and Welfare
ID : H24-tyoujyu-ippan-004
Organisme : Japan Science and Technology Agency
Organisme : Strategic Basic Research Programs (RISTEX Redesigning Communities for Aged Society)
Organisme : Japan Agency for Medical Research and Development (AMED)
ID : 18dk0110021h0003
Organisme : Japan Agency for Medical Research and Development (AMED)
ID : 18le0110004h0002
Organisme : Japan Agency for Medical Research and Development (AMED)
ID : 15dk0207004h0203
Organisme : Japan Agency for Medical Research and Development (AMED)
ID : 15dk0107003h0003
Organisme : Japan Agency for Medical Research and Development (AMED)
ID : 15dk0207019h0001
Organisme : National Center for Geriatrics and Gerontology
ID : 24-18
Organisme : National Center for Geriatrics and Gerontology
ID : 25-26
Organisme : National Center for Geriatrics and Gerontology
ID : 26-33
Organisme : National Center for Geriatrics and Gerontology
ID : 27-22
Organisme : National Center for Geriatrics and Gerontology
ID : 28-30
Organisme : National Center for Geriatrics and Gerontology
ID : 29-31
Organisme : National Center for Geriatrics and Gerontology
ID : 29-42
Informations de copyright
© 2022 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders.
Références
PLoS One. 2016 Jul 14;11(7):e0158720
pubmed: 27415430
BMC Geriatr. 2018 Nov 8;18(1):271
pubmed: 30409120
Age Ageing. 2019 Jan 1;48(1):16-31
pubmed: 30312372
Arch Gen Psychiatry. 1983 Jul;40(7):812
pubmed: 6860082
J Gerontol B Psychol Sci Soc Sci. 1999 Sep;54(5):S245-51
pubmed: 10542826
J Clin Epidemiol. 2012 Sep;65(9):989-95
pubmed: 22742913
Psychopharmacol Bull. 1988;24(4):709-11
pubmed: 3249773
Am J Epidemiol. 2008 Jan 15;167(2):240-8
pubmed: 17906296
Public Health Nurs. 2006 Jul-Aug;23(4):324-31
pubmed: 16817803
J Am Med Dir Assoc. 2020 Dec;21(12):2017.e1-2017.e9
pubmed: 32641273
J Cachexia Sarcopenia Muscle. 2019 Feb;10(1):188-198
pubmed: 30920779
J Cachexia Sarcopenia Muscle. 2018 Apr;9(2):269-278
pubmed: 29349935
J Am Med Dir Assoc. 2020 Mar;21(3):300-307.e2
pubmed: 32033882
Clin Interv Aging. 2017 May 17;12:835-845
pubmed: 28553092
J Frailty Aging. 2018;7(1):2-9
pubmed: 29412436
Arch Intern Med. 2009 Jun 22;169(12):1139-46
pubmed: 19546415
Phys Ther. 2005 Oct;85(10):1008-119
pubmed: 16180950
Am J Geriatr Psychiatry. 2006 Feb;14(2):139-44
pubmed: 16473978
Maturitas. 2018 Jul;113:26-31
pubmed: 29903645
J Cachexia Sarcopenia Muscle. 2021 Dec;12(6):2259-2261
pubmed: 34904399
Exp Aging Res. 2007 Jan-Mar;33(1):77-93
pubmed: 17132565
J Am Geriatr Soc. 2014 Apr;62(4):615-21
pubmed: 24655124
Clin Interv Aging. 2020 Sep 16;15:1675-1690
pubmed: 32982201
Eur J Phys Rehabil Med. 2013 Feb;49(1):131-43
pubmed: 23575207
J Sport Health Sci. 2021 Sep;10(5):577-584
pubmed: 34088651
Clin Interv Aging. 2020 Sep 15;15:1665-1674
pubmed: 32982200
Int Rehabil Med. 1985;7(4):182-6
pubmed: 4093250
PLoS One. 2015 Aug 07;10(8):e0135308
pubmed: 26252537
J Cachexia Sarcopenia Muscle. 2022 Jun;13(3):1919-1926
pubmed: 35437935
J Gerontol A Biol Sci Med Sci. 2011 Apr;66(4):467-73
pubmed: 21300745
J Am Med Dir Assoc. 2021 Sep 21;:
pubmed: 34560017
Psychol Med. 1982 May;12(2):397-408
pubmed: 7100362
J Gerontol A Biol Sci Med Sci. 2016 Nov;71(11):1466-1471
pubmed: 26975981
BMC Geriatr. 2020 Jan 31;20(1):35
pubmed: 32005107
J Gerontol A Biol Sci Med Sci. 2018 May 9;73(6):828-834
pubmed: 28977377